Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.63M

combined est. value

Stock	Shares	Price	Value	Weight	As of
NTLAIntellia Therapeutics, Inc.	156,286	$16.84	$2.63M	100%	2026-07-02

NTLA

Intellia Therapeutics, Inc.

$2.63M

156,286 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 3

Stock	Transaction	Date	~6mo later
NTLAIntellia Therapeutics, Inc.	Sell $84.2K · 4,677 sh	2026-07-02	—
NTLAIntellia Therapeutics, Inc.	Grant — · 61,280 sh	2026-03-01	—
NTLAIntellia Therapeutics, Inc.	Sell $58.8K · 6,379 sh	2026-01-05	—
NTLAIntellia Therapeutics, Inc.	Sell $104.6K · 7,462 sh	2025-07-23	—

NTLASell

2026-07-02 · Intellia Therapeutics, Inc.

$84.2K

—

NTLAGrant

2026-03-01 · Intellia Therapeutics, Inc.

61,280

—

NTLASell

2026-01-05 · Intellia Therapeutics, Inc.

$58.8K

—

NTLASell

2025-07-23 · Intellia Therapeutics, Inc.

$104.6K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.